UK markets closed

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
45.30-0.60 (-1.31%)
At close: 04:00PM EDT
44.65 -0.65 (-1.43%)
After hours: 05:32PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.63B
Enterprise value 2.56B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.01
Price/book (mrq)5.89
Enterprise value/revenue 4.92
Enterprise value/EBITDA 1.30k

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-22.62%
S&P500 52-week change 323.76%
52-week high 371.85
52-week low 336.73
50-day moving average 343.99
200-day moving average 354.42

Share statistics

Avg vol (3-month) 31.24M
Avg vol (10-day) 3670.41k
Shares outstanding 558.14M
Implied shares outstanding 658.14M
Float 849.75M
% held by insiders 19.34%
% held by institutions 1102.53%
Shares short (15 May 2024) 44.84M
Short ratio (15 May 2024) 43.96
Short % of float (15 May 2024) 410.54%
Short % of shares outstanding (15 May 2024) 48.32%
Shares short (prior month 15 Apr 2024) 43.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -4.54%
Operating margin (ttm)-5.65%

Management effectiveness

Return on assets (ttm)-0.68%
Return on equity (ttm)-5.41%

Income statement

Revenue (ttm)520.66M
Revenue per share (ttm)9.05
Quarterly revenue growth (yoy)23.30%
Gross profit (ttm)N/A
EBITDA -783k
Net income avi to common (ttm)-23.62M
Diluted EPS (ttm)-0.41
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)101.3M
Total cash per share (mrq)1.74
Total debt (mrq)31.49M
Total debt/equity (mrq)7.04%
Current ratio (mrq)2.71
Book value per share (mrq)7.71

Cash flow statement

Operating cash flow (ttm)25.65M
Levered free cash flow (ttm)46.67M